These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17983891)

  • 21. Penile rehabilitation following radical prostatectomy.
    Mulhall JP
    Curr Opin Urol; 2008 Nov; 18(6):613-20. PubMed ID: 18832948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDE5 inhibitors: is there more to come besides erectile dysfunction?
    Stief C
    Eur Urol; 2007 Oct; 52(4):943-4. PubMed ID: 17683851
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
    Burnett AL; Bivalacqua TJ; Champion HC; Musicki B
    Urology; 2006 May; 67(5):1043-8. PubMed ID: 16698365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centrally acting mechanisms for the treatment of male sexual dysfunction.
    Miner MM; Seftel AD
    Urol Clin North Am; 2007 Nov; 34(4):483-96, v. PubMed ID: 17983889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PDE5 inhibitors and satisfaction of patients with erectile dysfunction].
    Cour F
    Prog Urol; 2008 Sep; 18(8):542. PubMed ID: 18760745
    [No Abstract]   [Full Text] [Related]  

  • 26. Phosphodiesterase type 5 inhibithors in older males.
    Frajese GV; Pozzi F
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):112-5. PubMed ID: 16760638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy and erectile dysfunction: the current status.
    Lau DH; Kommu SS; Siddiqui EJ; Thompson CS; Morgan RJ; Mikhailidis DP; Mumtaz FH
    Asian J Androl; 2007 Jan; 9(1):8-15. PubMed ID: 16888683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and expectations of patients with erectile dysfunction: results of the SCORED study.
    Claes H; Opsomer RJ; Andrianne R; Vanbelle S; Albert A; Vanderdonck F
    Int J Impot Res; 2008; 20(4):418-24. PubMed ID: 18418390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health.
    Burnett AL
    J Androl; 2008; 29(1):3-14. PubMed ID: 17942972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.
    Aversa A; Pili M; Fabbri A; Spera E; Spera G
    J Endocrinol Invest; 2004 Feb; 27(2):192-206. PubMed ID: 15129818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erectile dysfunction and obstructive sleep apnea syndrome].
    Zhuravlev VN; Frank MA; Gomzhin AI
    Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of the application of cialis for erectile dysfunction].
    Koroleva SV; Apolikhin OI; Kovalev VA
    Urologiia; 2003; (6):61-4. PubMed ID: 14708250
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Rosen RC; Shaw JW
    Int J Impot Res; 2006; 18(6):570-1; author reply 572-3. PubMed ID: 17075585
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct androgen regulation of PDE5 gene or the lack thereof.
    Lin CS; Xin Z; Namiki M; Albersen M; Muller D; Lue TF
    Int J Impot Res; 2013 May; 25(3):81-5. PubMed ID: 23486196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury.
    Ahn BO; Kang KK; Ahn GJ; Kwon JW; Kim WB; Kang KS; Lee YS
    Int J Impot Res; 2003 Dec; 15(6):405-11. PubMed ID: 14671658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.
    Bunnage ME; Mathias JP; Wood A; Miller D; Street SD
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6033-6. PubMed ID: 18951784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is penile length a factor in treatment of erectile dysfunction with PDE-5 inhibitor?
    Savas M; Yeni E; Ciftci H; Topal U; Utangac M; Verit A
    J Androl; 2009; 30(5):515-9. PubMed ID: 19234311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with phosphodiesterase type 5 inhibitor treatment satisfactions: results of patient interrogation.
    Cimen S; Demir O; Aslan G; Esen AA
    Aging Male; 2009; 12(2-3):58-61. PubMed ID: 19562633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.